ArticleInternational journal of endocrine oncology
Emerging therapy for adrenocortical carcinoma.
Article in International journal of endocrine oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 18 citations in OpenAlex.
- Clinical outcomes of image-guided therapies in patients with adrenocortical carcinoma: a tertiary referral center retrospective study.The oncologist · 2024Article
- Identification of a chromatin regulator signature and potential prognostic ability for adrenocortical carcinoma.Frontiers in genetics · 2022Article
- Giant Adrenocortical Carcinoma: A Case Report and Review of the Relevant Literature.The American journal of case reports · 2021Article
- Successful treatment of metastatic adrenocortical carcinoma in the spine: A case report and literature review.Medicine · 2019Review
- Common module analysis reveals prospective targets and mechanisms of pediatric adrenocortical adenoma and carcinoma.Oncology letters · 2018Article
- Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms.Clinical cancer research : an official journal of the American Association for Cancer Research · 2017Article
- Adrenocortical carcinoma: modern management and evolving treatment strategies.International journal of endocrine oncology · 2016Article
- Does Lymphadenectomy Improve Survival in Patients with Adrenocortical Carcinoma? A Population-Based Study.World journal of surgery · 2016Article
- Adrenocortical carcinoma with inferior vena cava, left renal vein and right atrium tumor thrombus extension.International journal of surgery case reports · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Adrenocortical carcinoma (ACC) is a very rare and aggressive tumor with dismal outcomes. Best current treatments include complete surgical resection for localized resectable disease and systemic therapy with mitotane alone or in combination for advanced ACC. Advances in molecular genetic profiling of ACC have created multiple new targets for potential treatment options in ACC. This article reviews the current treatment options available for ACC and discusses the potential new targets identified through molecular profiling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.